CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,277,113 | +25.3% | 1,401,124 | +38.7% | 0.01% | +66.7% |
| Q2 2023 | $32,945,841 | +1400.4% | 1,009,989 | +1518.6% | 0.01% | – |
| Q1 2023 | $2,195,856 | -75.6% | 62,400 | -68.2% | 0.00% | -100.0% |
| Q4 2022 | $8,983,607 | -66.9% | 196,063 | -65.0% | 0.00% | -60.0% |
| Q3 2022 | $27,177,000 | -85.3% | 560,955 | -88.1% | 0.01% | -89.4% |
| Q2 2022 | $185,120,000 | +1536.9% | 4,711,627 | +1433.5% | 0.05% | +2250.0% |
| Q1 2022 | $11,309,000 | +177.7% | 307,250 | +243.9% | 0.00% | – |
| Q4 2021 | $4,072,000 | -69.5% | 89,333 | -76.1% | 0.00% | -100.0% |
| Q3 2021 | $13,338,000 | +330.3% | 373,207 | +138.2% | 0.00% | – |
| Q2 2021 | $3,100,000 | -68.3% | 156,674 | -62.7% | 0.00% | -100.0% |
| Q1 2021 | $9,776,000 | +96.5% | 420,316 | +75.6% | 0.00% | +100.0% |
| Q4 2020 | $4,974,000 | -85.3% | 239,371 | -84.6% | 0.00% | -90.0% |
| Q3 2020 | $33,745,000 | +57.2% | 1,558,649 | +71.1% | 0.01% | +25.0% |
| Q2 2020 | $21,472,000 | +23.0% | 911,025 | -38.5% | 0.01% | 0.0% |
| Q1 2020 | $17,460,000 | +583.1% | 1,480,916 | +514.8% | 0.01% | +700.0% |
| Q4 2019 | $2,556,000 | +219.9% | 240,892 | +243.2% | 0.00% | – |
| Q3 2019 | $799,000 | -22.7% | 70,198 | -23.6% | 0.00% | – |
| Q2 2019 | $1,034,000 | -33.5% | 91,939 | -52.1% | 0.00% | -100.0% |
| Q1 2019 | $1,555,000 | +11.6% | 192,129 | -12.8% | 0.00% | 0.0% |
| Q4 2018 | $1,393,000 | +787.3% | 220,453 | +1286.5% | 0.00% | – |
| Q3 2018 | $157,000 | -74.9% | 15,900 | -78.9% | 0.00% | – |
| Q2 2018 | $626,000 | -71.7% | 75,501 | -75.4% | 0.00% | -100.0% |
| Q1 2018 | $2,213,000 | -49.3% | 307,269 | -42.6% | 0.00% | -50.0% |
| Q4 2017 | $4,361,000 | -77.1% | 535,077 | -59.3% | 0.00% | -85.7% |
| Q3 2017 | $19,045,000 | +1298.3% | 1,313,497 | +1066.9% | 0.01% | +1300.0% |
| Q2 2017 | $1,362,000 | +417.9% | 112,563 | +449.1% | 0.00% | – |
| Q1 2017 | $263,000 | -13.2% | 20,500 | -18.0% | 0.00% | – |
| Q4 2016 | $303,000 | -36.9% | 25,004 | -52.1% | 0.00% | – |
| Q3 2016 | $480,000 | +366.0% | 52,246 | +259.1% | 0.00% | – |
| Q1 2016 | $103,000 | +98.1% | 14,551 | +192.5% | 0.00% | – |
| Q4 2015 | $52,000 | -63.6% | 4,975 | -76.7% | 0.00% | – |
| Q3 2015 | $143,000 | +10.0% | 21,363 | +10.4% | 0.00% | – |
| Q2 2015 | $130,000 | -89.4% | 19,347 | -89.3% | 0.00% | -100.0% |
| Q1 2015 | $1,230,000 | +29.6% | 181,362 | +53.1% | 0.00% | 0.0% |
| Q4 2014 | $949,000 | +213.2% | 118,464 | +37.6% | 0.00% | – |
| Q3 2014 | $303,000 | +173.0% | 86,098 | +270.2% | 0.00% | – |
| Q2 2014 | $111,000 | -91.9% | 23,255 | -83.9% | 0.00% | -100.0% |
| Q1 2014 | $1,372,000 | – | 144,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |